| 1 |
29263648 | Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro. | 2017 |
7 |
| 2 |
23530020 | Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation. | 2013 Jun |
2 |
| 3 |
18679666 | Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. | 2008 Dec |
1 |
| 4 |
18846481 | Human CYP3A4-introduced HepG2 cells: in vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity. | 2008 Nov |
1 |
| 5 |
16894333 | Lidocaine pharmacokinetics in postmenopausal women on hormone therapy. | 2006 Sep-Oct |
1 |
| 6 |
16918719 | Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. | 2006 Aug |
5 |
| 7 |
15845683 | The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. | 2005 May |
4 |
| 8 |
16435566 | The effects of gender and menopause on serum lidocaine levels in smokers. | 2005 Oct-Dec |
1 |
| 9 |
14715049 | Pharmacokinetics of local anaesthetics in infants and children. | 2004 |
1 |
| 10 |
15383492 | Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. | 2004 Dec |
1 |
| 11 |
15447735 | Effect of itraconazole on the pharmacokinetics of inhaled lidocaine. | 2004 Sep |
3 |
| 12 |
12534644 | Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. | 2003 Jan |
1 |
| 13 |
12708606 | The effect of propofol (anesthetic and inhibitor of CYP3A4) on serum lidocaine concentrations in smokers and chronic alcohol consumers. | 2003 Apr |
1 |
| 14 |
12483453 | Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. | 2002 Dec |
1 |
| 15 |
10786743 | The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro. | 2000 May |
1 |
| 16 |
10901707 | Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. | 2000 Aug |
1 |
| 17 |
10193676 | Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine. | 1999 Mar |
4 |
| 18 |
10608481 | Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. | 1999 Nov |
4 |
| 19 |
9832299 | Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine. | 1998 Sep |
1 |
| 20 |
9862241 | The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans. | 1998 Dec |
2 |
| 21 |
9143866 | Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes. | 1997 |
2 |
| 22 |
9298257 | Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: evaluation of model drugs terfenadine and rifampin. | 1997 Jul |
1 |
| 23 |
8891878 | Interaction between amiodarone and lidocaine. | 1996 Oct |
1 |
| 24 |
8953808 | Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man. | 1996 Jul-Aug |
1 |
| 25 |
7636727 | Rifampicin induction of lidocaine metabolism in cultured human hepatocytes. | 1995 Aug |
1 |
| 26 |
7756103 | CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. | 1995 Jan |
2 |
| 27 |
8033500 | Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men. | 1994 Jul |
1 |
| 28 |
1642641 | Effect of age and gender on the activity of human hepatic CYP3A. | 1992 Jul 22 |
1 |